Delivery Order SPE2DB20D1047-SPE2DB25FF36R

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of azithromycin 250 mg tablets. The $2,591.86 Firm Fixed Price contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with a period of performance through November 2024. The contract does not have a set-aside designation, indicating open competition. As a key supplier of pharmaceuticals and medical supplies...
This federal contract award, valued at $108,683.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4534332037 tablets of Azithromycin 500 mg, a generic antibiotic medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,426.23 firm fixed-price delivery order is for the supply of 4,567,001,515 units of azithromycin 250mg tablets. The contract has an ultimate completion date of February 19, 2025 and was awarded on January 22, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA...
This federal contract award is for the delivery of Azithromycin 500 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 10, 2024 with a ceiling value of $1,037.30. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of Azithromycin 250 mg tablets, a pharmaceutical product, at a ceiling value of $1,132.92. The contract has a completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at up to $999,999,999...
This federal contract award, with ID SPE2DB20D3101 and SPE2DB25FQZT9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,567,027,871 units of Azithromycin 250 mg tablets, with a total ceiling value of $1,628.52. It is a firm-fixed-price delivery order contract with a completion date of January 24, 2025. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $1,770.83 firm fixed-price delivery order is for the supply of 4,561,596,335 units of azithromycin 500 mg tablets. The contract has a completion date of July 26, 2023 and was awarded on July 25, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,984.76, is for the delivery of 4554468041 - AZITHROMYCIN 500 MG TABLET 30S. This is a firm fixed-price delivery order contract with an ultimate completion date of August 19, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency awarded a $138,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mg azithromycin tablets. Under this order, Amerisourcebergen will deliver 6 packs of the antibiotic tablets to a location in Conshohocken, Pennsylvania by July 14, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders for various medications through the DLA's prime vendor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,615.17, is for the delivery of the medication Zileuton ER 600 mg Tablet in quantities of 120 tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF36R
    Delivery Order

This federal contract award, valued at $1,561.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Azithromycin 250 mg tablets and does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/21/25, 3:45 AM